TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs492146
log Bayes Factor = 3.58103
Chromosome 6   position 52,835,895  (GRCh37) Explore rs492146 on Ensembl!
Variant rs492146 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.000 0.009 0.991
T36-T50 Poisoning by drugs, medicaments and biological substances
0.000 0.011 0.989
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.000 0.013 0.987
T43.0 Tricyclic and tetracyclic antidepressants
0.000 0.027 0.973
E23 Hypofunction and other disorders of pituitary gland
0.000 0.034 0.966
T42.4 Benzodiazepines
0.000 0.036 0.964
E20-E35 Disorders of other endocrine glands
0.000 0.037 0.963
T43.2 Other and unspecified antidepressants
0.000 0.040 0.960
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.000 0.041 0.959
E27 Other disorders of adrenal gland
0.000 0.042 0.958
E27.1 Primary adrenocortical insufficiency
0.000 0.046 0.954
E23.0 Hypopituitarism
0.000 0.051 0.949
E23.2 Diabetes insipidus
0.000 0.067 0.933
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.000 0.074 0.926
T43.3 Phenothiazine antipsychotics and neuroleptics
0.000 0.101 0.899
T46 Poisoning by agents primarily affecting the cardiovascular system
0.000 0.103 0.897
T43.5 Other and unspecified antipsychotics and neuroleptics
0.000 0.115 0.885
E23.6 Other disorders of pituitary gland
0.000 0.119 0.881
E22 Hyperfunction of pituitary gland
0.000 0.126 0.874
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.000 0.143 0.857
T40.2 Other opioids
0.000 0.159 0.841
E23.7 Disorder of pituitary gland, unspecified
0.000 0.185 0.815
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.000 0.189 0.811
E28 Ovarian dysfunction
0.000 0.192 0.808
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.000 0.200 0.800
E22.1 Hyperprolactinaemia
0.000 0.204 0.796
T43.6 Psychostimulants with abuse potential
0.000 0.209 0.791
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.000 0.218 0.782
T46.3 Coronary vasodilators, not elsewhere classified
0.000 0.225 0.775
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.000 0.226 0.774
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.228 0.772
E22.0 Acromegaly and pituitary gigantism
0.000 0.233 0.767
E24 Cushing's syndrome
0.000 0.234 0.766
E27.8 Other specified disorders of adrenal gland
0.000 0.236 0.764
T40.5 Cocaine
0.000 0.239 0.761
E28.3 Primary ovarian failure
0.000 0.253 0.747
E27.4 Other and unspecified adrenocortical insufficiency
0.000 0.254 0.746
T43.4 Butyrophenone and thioxanthene neuroleptics
0.000 0.260 0.740
E27.3 Drug-induced adrenocortical insufficiency
0.000 0.261 0.739
T46.4 Angiotensin-converting-enzyme inhibitors
0.000 0.264 0.736
E26 Hyperaldosteronism
0.000 0.267 0.732
E31 Polyglandular dysfunction
0.000 0.269 0.731
E34 Other endocrine disorders
0.000 0.282 0.718
T46.1 Calcium-channel blockers
0.000 0.285 0.715
T43.8 Other psychotropic drugs, not elsewhere classified
0.000 0.290 0.710
T42.1 Iminostilbenes
0.000 0.290 0.710
T41 Poisoning by anaesthetics and therapeutic gases
0.000 0.291 0.709
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.000 0.291 0.709
T42.5 Mixed antiepileptics, not elsewhere classified
0.000 0.292 0.707
T42.2 Succinimides and oxazolidinediones
0.000 0.292 0.707
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.000 0.307 0.693
E23.1 Drug-induced hypopituitarism
0.000 0.307 0.693
E35 Disorders of endocrine glands in diseases classified elsewhere
0.000 0.309 0.691
E32 Diseases of thymus
0.000 0.309 0.691
E30 Disorders of puberty, not elsewhere classified
0.000 0.309 0.691
T40.1 Heroin
0.000 0.310 0.690
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.000 0.311 0.689
E27.5 Adrenomedullary hyperfunction
0.000 0.313 0.687
E27.0 Other adrenocortical overactivity
0.000 0.313 0.687
T43.9 Psychotropic drug, unspecified
0.000 0.319 0.681
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.000 0.319 0.681
E29 Testicular dysfunction
0.000 0.320 0.680
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.000 0.321 0.679
E20 Hypoparathyroidism
0.000 0.327 0.673
T40.4 Other synthetic narcotics
0.000 0.327 0.672
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.331 0.668
T40.6 Other and unspecified narcotics
0.000 0.334 0.666
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.000 0.336 0.664
T40.8 Lysergide [LSD]
0.000 0.336 0.664
T40.7 Cannabis (derivatives)
0.000 0.336 0.664
T40.3 Methadone
0.000 0.336 0.664
T40.0 Opium
0.000 0.336 0.664
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.000 0.338 0.662
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.000 0.348 0.652
T42.0 Hydantoin derivatives
0.000 0.349 0.651
T42.3 Barbiturates
0.000 0.351 0.649
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.000 0.354 0.646
T46.8 Antivaricose drugs, including sclerosing agents
0.000 0.357 0.643
T46.7 Peripheral vasodilators
0.000 0.357 0.643
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.361 0.639
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.000 0.362 0.638
T38.1 Thyroid hormones and substitutes
0.000 0.362 0.638
E25 Adrenogenital disorders
0.000 0.366 0.634
E24.0 Pituitary-dependent Cushing's disease
0.000 0.370 0.630
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.000 0.371 0.629
E22.9 Hyperfunction of pituitary gland, unspecified
0.000 0.373 0.626
E22.8 Other hyperfunction of pituitary gland
0.000 0.373 0.626
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.000 0.375 0.624
E21.0 Primary hyperparathyroidism
0.000 0.381 0.619
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.383 0.617
T38.8 Other and unspecified hormones and their synthetic substitutes
0.000 0.383 0.617
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.000 0.385 0.614
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.000 0.385 0.614
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.000 0.385 0.614
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.000 0.385 0.614
T44.1 Other parasympathomimetics [cholinergics]
0.000 0.385 0.614
T44.0 Anticholinesterase agents
0.000 0.385 0.614
E24.9 Cushing's syndrome, unspecified
0.000 0.388 0.612
T36 Poisoning by systemic antibiotics
0.000 0.390 0.610
E34.0 Carcinoid syndrome
0.000 0.395 0.605
E27.2 Addisonian crisis
0.000 0.396 0.604
T45.0 Antiallergic and antiemetic drugs
0.000 0.400 0.600
E28.9 Ovarian dysfunction, unspecified
0.000 0.421 0.579
E28.8 Other ovarian dysfunction
0.000 0.421 0.579
E28.1 Androgen excess
0.000 0.421 0.579
E28.0 Oestrogen excess
0.000 0.421 0.579
T45.5 Anticoagulants
0.000 0.423 0.577
T38.9 Other and unspecified hormone antagonists
0.000 0.427 0.573
T38.7 Androgens and anabolic congeners
0.000 0.427 0.573
T38.5 Other oestrogens and progestogens
0.000 0.427 0.573
T38.4 Oral contraceptives
0.000 0.427 0.573
T38.2 Antithyroid drugs
0.000 0.427 0.573
E31.0 Autoimmune polyglandular failure
0.000 0.435 0.565
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.438 0.562
T45.1 Antineoplastic and immunosuppressive drugs
0.000 0.444 0.556
T45.9 Primarily systemic and haematological agent, unspecified
0.000 0.445 0.555
T45.8 Other primarily systemic and haematological agents
0.000 0.445 0.555
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.000 0.445 0.555
T45.6 Fibrinolysis-affecting drugs
0.000 0.445 0.555
T45.4 Iron and its compounds
0.000 0.445 0.555
T45.3 Enzymes, not elsewhere classified
0.000 0.445 0.555
T45.2 Vitamins, not elsewhere classified
0.000 0.445 0.555
E27.9 Disorder of adrenal gland, unspecified
0.000 0.448 0.552
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.000 0.450 0.550
E24.3 Ectopic ACTH syndrome
0.000 0.450 0.550
E24.1 Nelson's syndrome
0.000 0.450 0.550
E26.0 Primary hyperaldosteronism
0.000 0.452 0.548
E26.9 Hyperaldosteronism, unspecified
0.000 0.453 0.547
T50.8 Diagnostic agents
0.000 0.470 0.530
E24.8 Other Cushing's syndrome
0.000 0.472 0.528
T38.0 Glucocorticoids and synthetic analogues
0.000 0.474 0.526
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.000 0.474 0.526
E21.2 Other hyperparathyroidism
0.000 0.474 0.526
E26.8 Other hyperaldosteronism
0.000 0.475 0.525
E26.1 Secondary hyperaldosteronism
0.000 0.475 0.525
T47.1 Other antacids and anti-gastric-secretion drugs
0.000 0.475 0.525
E31.9 Polyglandular dysfunction, unspecified
0.000 0.475 0.524
E31.8 Other polyglandular dysfunction
0.000 0.475 0.524
E31.1 Polyglandular hyperfunction
0.000 0.475 0.524
E34.5 Androgen resistance syndrome
0.000 0.485 0.515
E34.4 Constitutional tall stature
0.000 0.485 0.515
E34.2 Ectopic hormone secretion, not elsewhere classified
0.000 0.485 0.515
E34.1 Other hypersecretion of intestinal hormones
0.000 0.485 0.515
T41.5 Therapeutic gases
0.000 0.491 0.509
T41.4 Anaesthetic, unspecified
0.000 0.491 0.509
T41.3 Local anaesthetics
0.000 0.491 0.509
T41.2 Other and unspecified general anaesthetics
0.000 0.491 0.509
T41.1 Intravenous anaesthetics
0.000 0.491 0.509
T41.0 Inhaled anaesthetics
0.000 0.491 0.509
T36.0 Penicillins
0.000 0.499 0.501
E34.9 Endocrine disorder, unspecified
0.000 0.502 0.498
E30.9 Disorder of puberty, unspecified
0.000 0.505 0.495
E30.8 Other disorders of puberty
0.000 0.505 0.495
E30.1 Precocious puberty
0.000 0.505 0.495
E30.0 Delayed puberty
0.000 0.505 0.495
E32.9 Disease of thymus, unspecified
0.000 0.505 0.495
E32.8 Other diseases of thymus
0.000 0.505 0.495
E32.1 Abscess of thymus
0.000 0.505 0.495
E32.0 Persistent hyperplasia of thymus
0.000 0.505 0.495
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.000 0.505 0.495
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.000 0.505 0.495
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.000 0.505 0.495
E29.1 Testicular hypofunction
0.000 0.505 0.495
E34.3 Short stature, not elsewhere classified
0.000 0.506 0.494
T49.9 Topical agent, unspecified
0.000 0.506 0.494
T49.8 Other topical agents
0.000 0.506 0.494
T49.7 Dental drugs, topically applied
0.000 0.506 0.494
T49.6 Otorhinolaryngological drugs and preparations
0.000 0.506 0.494
T49.5 Ophthalmological drugs and preparations
0.000 0.506 0.494
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.000 0.506 0.494
T49.3 Emollients, demulcents and protectants
0.000 0.506 0.494
T49.2 Local astringents and local detergents
0.000 0.506 0.494
T49.1 Antipruritics
0.000 0.506 0.494
E29.8 Other testicular dysfunction
0.000 0.512 0.487
E29.0 Testicular hyperfunction
0.000 0.512 0.487
T47.0 Histamine H(2)-receptor antagonists
0.000 0.513 0.487
T47.6 Antidiarrhoeal drugs
0.000 0.513 0.487
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.000 0.513 0.486
T47.8 Other agents primarily affecting the gastro-intestinal system
0.000 0.513 0.486
T47.7 Emetics
0.000 0.513 0.486
T47.5 Digestants
0.000 0.513 0.486
T47.3 Saline and osmotic laxatives
0.000 0.513 0.486
E20.8 Other hypoparathyroidism
0.000 0.517 0.483
E20.1 Pseudohypoparathyroidism
0.000 0.517 0.483
E20.0 Idiopathic hypoparathyroidism
0.000 0.517 0.483
E24.2 Drug-induced Cushing's syndrome
0.000 0.519 0.481
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.000 0.527 0.473
T50.9 Other and unspecified drugs, medicaments and biological substances
0.000 0.527 0.473
E21.5 Disorder of parathyroid gland, unspecified
0.000 0.531 0.469
E29.9 Testicular dysfunction, unspecified
0.000 0.532 0.468
T47.2 Stimulant laxatives
0.000 0.533 0.467
T48.6 Antiasthmatics, not elsewhere classified
0.000 0.534 0.465
E20.9 Hypoparathyroidism, unspecified
0.000 0.535 0.465
T50.7 Analeptics and opioid receptor antagonists
0.000 0.537 0.463
T50.5 Appetite depressants
0.000 0.537 0.463
T50.3 Electrolytic, caloric and water-balance agents
0.000 0.537 0.463
T50.0 Mineralocorticoids and their antagonists
0.000 0.537 0.463
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.000 0.538 0.462
E25.9 Adrenogenital disorder, unspecified
0.000 0.545 0.455
E25.8 Other adrenogenital disorders
0.000 0.545 0.455
E34.8 Other specified endocrine disorders
0.000 0.548 0.452
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.000 0.549 0.451
T37.5 Antiviral drugs
0.000 0.549 0.451
T37.4 Anthelminthics
0.000 0.549 0.451
T37.3 Other antiprotozoal drugs
0.000 0.549 0.451
T37.1 Antimycobacterial drugs
0.000 0.549 0.451
T37.0 Sulphonamides
0.000 0.549 0.451
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.000 0.552 0.448
T48.4 Expectorants
0.000 0.552 0.448
T48.3 Antitussives
0.000 0.552 0.448
T48.2 Other and unspecified agents primarily acting on muscles
0.000 0.552 0.448
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.000 0.552 0.448
T48.0 Oxytocic drugs
0.000 0.552 0.448
T50.6 Antidotes and chelating agents, not elsewhere classified
0.000 0.556 0.444
T50.1 Loop [high-ceiling] diuretics
0.000 0.556 0.443
T36.9 Systemic antibiotic, unspecified
0.000 0.562 0.437
T36.7 Antifungal antibiotics, systemically used
0.000 0.562 0.437
T36.6 Rifamycins
0.000 0.562 0.437
T36.5 Aminoglycosides
0.000 0.562 0.437
T36.2 Chloramphenicol group
0.000 0.562 0.437
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.000 0.562 0.437
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.000 0.566 0.434
T37.2 Antimalarials and drugs acting on other blood protozoa
0.000 0.567 0.433
T46.5 Other antihypertensive drugs, not elsewhere classified
0.001 0.572 0.428
E21.4 Other specified disorders of parathyroid gland
0.000 0.573 0.427
T47.4 Other laxatives
0.000 0.574 0.426
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.000 0.575 0.425
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.000 0.591 0.409
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.000 0.596 0.404
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.000 0.601 0.398
T37.8 Other specified systemic anti-infectives and antiparasitics
0.000 0.605 0.394
E28.2 Polycystic ovarian syndrome
0.000 0.609 0.391
T36.8 Other systemic antibiotics
0.000 0.617 0.382
T36.4 Tetracyclines
0.000 0.617 0.382
T50.4 Drugs affecting uric acid metabolism
0.000 0.634 0.365
T36.3 Macrolides
0.000 0.636 0.363
T39.0 Salicylates
0.000 0.644 0.356
T48.5 Anti-common-cold drugs
0.001 0.666 0.333
T39.4 Antirheumatics, not elsewhere classified
0.000 0.668 0.332
T39.2 Pyrazolone derivatives
0.000 0.668 0.332
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.000 0.675 0.325
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.000 0.693 0.307
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.000 0.695 0.305
E21.3 Hyperparathyroidism, unspecified
0.000 0.700 0.300
T39.1 4-Aminophenol derivatives
0.000 0.847 0.153
R91 Abnormal findings on diagnostic imaging of lung
0.000 0.915 0.085
I46.0 Cardiac arrest with successful resuscitation
0.071 0.929 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.045 0.955 0.000
R63.0 Anorexia
0.000 0.963 0.037
C44.5 Skin of trunk
0.030 0.970 0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs
0.000 0.981 0.019
R90-R94 Abnormal findings on diagnostic imaging and in function studies, without diagnosis
0.000 0.982 0.018
I46 Cardiac arrest
0.018 0.982 0.000
B37.8 Candidiasis of other sites
0.017 0.983 0.000
R93 Abnormal findings on diagnostic imaging of other body structures
0.000 0.985 0.015
S32.00 Fracture of lumbar vertebra (closed)
0.013 0.987 0.000
I65.2 Occlusion and stenosis of carotid artery
0.013 0.987 0.000
I46.1 Sudden cardiac death, so described
0.013 0.987 0.000
R90 Abnormal findings on diagnostic imaging of central nervous system
0.000 0.988 0.012
R92 Abnormal findings on diagnostic imaging of breast
0.000 0.988 0.012
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
0.000 0.988 0.012
R93.8 Abnormal findings on diagnostic imaging of other specified body structures
0.000 0.989 0.011
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract
0.000 0.989 0.011
R93.6 Abnormal findings on diagnostic imaging of limbs
0.000 0.990 0.010
V18.2 Unspecified pedal cyclist injured in nontraffic accident
0.010 0.990 0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation
0.000 0.991 0.009
V18 Pedal cyclist injured in noncollision transport accident
0.009 0.991 0.000
E89.2 Postprocedural hypoparathyroidism
0.000 0.991 0.009
R63 Symptoms and signs concerning food and fluid intake
0.000 0.991 0.009
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified
0.000 0.991 0.009
E89.3 Postprocedural hypopituitarism
0.000 0.991 0.009
V18.0 Driver injured in nontraffic accident
0.009 0.991 0.000
E89.0 Postprocedural hypothyroidism
0.000 0.991 0.009
R63.5 Abnormal weight gain
0.000 0.992 0.008
R90.0 Intracranial space-occupying lesion
0.000 0.992 0.008
R90.8 Other abnormal findings on diagnostic imaging of central nervous system
0.000 0.992 0.008
E89.6 Postprocedural adrenocortical(-medullary) hypofunction
0.000 0.992 0.008
V18.3 Person injured while boarding or alighting
0.008 0.992 0.000
V18.5 Passenger injured in traffic accident
0.007 0.993 0.000
R94 Abnormal results of function studies
0.000 0.993 0.007
S32.0 Fracture of lumbar vertebra
0.007 0.993 0.000
R63.1 Polydipsia
0.000 0.993 0.007
V18.9 Unspecified pedal cyclist injured in traffic accident
0.007 0.993 0.000
V18.4 Driver injured in traffic accident
0.007 0.993 0.000
R63.3 Feeding difficulties and mismanagement
0.000 0.993 0.007
T51.0 Ethanol
0.000 0.993 0.007
V18.1 Passenger injured in nontraffic accident
0.007 0.993 0.000
Z84.8 Family history of other specified conditions
0.007 0.993 0.000
I46.9 Cardiac arrest, unspecified
0.007 0.993 0.000
R63.2 Polyphagia
0.000 0.993 0.007
E89.9 Postprocedural endocrine and metabolic disorder, unspecified
0.000 0.993 0.007
E89.5 Postprocedural testicular hypofunction
0.000 0.993 0.007
R63.6 Insufficient intake of food and water due to self neglect
0.000 0.993 0.007
E89.8 Other postprocedural endocrine and metabolic disorders
0.000 0.993 0.007
R94.7 Abnormal results of other endocrine function studies
0.000 0.993 0.007
N84.1 Polyp of cervix uteri
0.007 0.993 0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
0.000 0.994 0.006
E89.1 Postprocedural hypoinsulinaemia
0.000 0.994 0.006
K72.9 Hepatic failure, unspecified
0.000 0.994 0.006
V10-V19 Pedal cyclist injured in transport accident
0.006 0.994 0.000
R94.0 Abnormal results of function studies of central nervous system
0.000 0.994 0.006
H43.8 Other disorders of vitreous body
0.006 0.994 0.000
R94.8 Abnormal results of function studies of other organs and systems
0.000 0.994 0.006
E89.4 Postprocedural ovarian failure
0.000 0.994 0.005
S32.01 Fracture of lumbar vertebra (open)
0.005 0.995 0.000
R94.4 Abnormal results of kidney function studies
0.000 0.995 0.005
R94.2 Abnormal results of pulmonary function studies
0.000 0.995 0.005
I05.1 Rheumatic mitral insufficiency
0.005 0.995 0.000
I84.3 External thrombosed haemorrhoids
0.000 0.995 0.005
V18.49 Pedal cyclist injured in noncollision transport accident; driver injured in traffic accident ; during unspecified activity
0.005 0.995 0.000
V18.99 Pedal cyclist injured in noncollision transport accident; unspecified pedal cyclist injured in traffic accident; during unspecified activity
0.005 0.995 0.000
I05.9 Mitral valve disease, unspecified
0.005 0.995 0.000
N75.0 Cyst of Bartholin's gland
0.000 0.995 0.005
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
0.000 0.995 0.005
R94.6 Abnormal results of thyroid function studies
0.000 0.995 0.005
I05 Rheumatic mitral valve diseases
0.005 0.995 0.000
I08.0 Disorders of both mitral and aortic valves
0.005 0.995 0.000
V13 Pedal cyclist injured in collision with car, pick-up truck or van
0.005 0.995 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.005 0.995 0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.005 0.995 0.000
B37 Candidiasis
0.005 0.995 0.000
S80.1 Contusion of other and unspecified parts of lower leg
0.005 0.995 0.000
T81.8 Other complications of procedures, not elsewhere classified
0.005 0.995 0.000
V10 Pedal cyclist injured in collision with pedestrian or animal
0.005 0.995 0.000
D17.6 Benign lipomatous neoplasm of spermatic cord
0.000 0.995 0.005
E14.9 Without complications
0.000 0.995 0.005
R94.1 Abnormal results of function studies of peripheral nervous system and special senses
0.000 0.995 0.005
B37.2 Candidiasis of skin and nail
0.005 0.995 0.000
B37.4 Candidiasis of other urogenital sites
0.005 0.995 0.000
V19 Pedal cyclist injured in other and unspecified transport accidents
0.005 0.995 0.000
V16 Pedal cyclist injured in collision with other nonmotor vehicle
0.004 0.995 0.000
V15 Pedal cyclist injured in collision with railway train or railway vehicle
0.004 0.995 0.000
V12 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle
0.004 0.995 0.000
V13.0 Driver injured in nontraffic accident
0.004 0.995 0.000
I05.2 Mitral stenosis with insufficiency
0.004 0.995 0.000
V11 Pedal cyclist injured in collision with other pedal cycle
0.004 0.995 0.000
B37.7 Candidal septicaemia
0.004 0.996 0.000
V17.0 Driver injured in nontraffic accident
0.004 0.996 0.000
C24.0 Extrahepatic bile duct
0.000 0.996 0.004
S80.0 Contusion of knee
0.004 0.996 0.000
V17.9 Unspecified pedal cyclist injured in traffic accident
0.004 0.996 0.000
V14 Pedal cyclist injured in collision with heavy transport vehicle or bus
0.004 0.996 0.000
Q38.7 Pharyngeal pouch
0.004 0.996 0.000
V10.4 Driver injured in traffic accident
0.004 0.996 0.000
I05.8 Other mitral valve diseases
0.004 0.996 0.000
M70.65 Trochanteric bursitis-Pelvic/Thigh
0.004 0.996 0.000
B37.1 Pulmonary candidiasis
0.004 0.996 0.000
V17.2 Unspecified pedal cyclist injured in nontraffic accident
0.004 0.996 0.000
C24.9 Biliary tract, unspecified
0.000 0.996 0.004
S80.8 Other superficial injuries of lower leg
0.004 0.996 0.000
V13.9 Unspecified pedal cyclist injured in traffic accident
0.004 0.996 0.000
V13.4 Driver injured in traffic accident
0.004 0.996 0.000
V13.2 Unspecified pedal cyclist injured in nontraffic accident
0.004 0.996 0.000
V13.5 Passenger injured in traffic accident
0.004 0.996 0.000
V13.3 Person injured while boarding or alighting
0.004 0.996 0.000
V13.1 Passenger injured in nontraffic accident
0.004 0.996 0.000
V17.5 Passenger injured in traffic accident
0.004 0.996 0.000
V17.3 Person injured while boarding or alighting
0.004 0.996 0.000
V17.1 Passenger injured in nontraffic accident
0.004 0.996 0.000
S80 Superficial injury of lower leg
0.004 0.996 0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery
0.004 0.996 0.000
I65.8 Occlusion and stenosis of other precerebral artery
0.004 0.996 0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries
0.004 0.996 0.000
B37.6 Candidal endocarditis
0.004 0.996 0.000
B37.5 Candidal meningitis
0.004 0.996 0.000
E10.3 With ophthalmic complications
0.000 0.996 0.004
I05.0 Mitral stenosis
0.004 0.996 0.000
I65.0 Occlusion and stenosis of vertebral artery
0.004 0.996 0.000
X62.9 Unspecified place
0.000 0.996 0.004
M06.40 Inflammatory polyarthropathy (Multiple sites)
0.004 0.996 0.000
V10.9 Unspecified pedal cyclist injured in traffic accident
0.004 0.996 0.000
V10.5 Passenger injured in traffic accident
0.004 0.996 0.000
V10.3 Person injured while boarding or alighting
0.004 0.996 0.000
V10.2 Unspecified pedal cyclist injured in nontraffic accident
0.004 0.996 0.000
V10.1 Passenger injured in nontraffic accident
0.004 0.996 0.000
V10.0 Driver injured in nontraffic accident
0.004 0.996 0.000
I21.4 Acute subendocardial myocardial infarction
0.004 0.996 0.000
V19.3 Pedal cyclist [any] injured in an unspecified nontraffic accident
0.004 0.996 0.000
V17.4 Driver injured in traffic accident
0.003 0.996 0.000
V19.9 Pedal cyclist [any] injured in unspecified traffic accident
0.003 0.996 0.000
V19.6 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
V19.2 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
V19.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
V19.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
V19.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident
0.003 0.996 0.000
V12.4 Driver injured in traffic accident
0.003 0.996 0.000
V12.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.996 0.000
V12.5 Passenger injured in traffic accident
0.003 0.996 0.000
V12.3 Person injured while boarding or alighting
0.003 0.996 0.000
V12.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.996 0.000
V12.1 Passenger injured in nontraffic accident
0.003 0.996 0.000
V12.0 Driver injured in nontraffic accident
0.003 0.996 0.000
V15.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.996 0.000
V15.5 Passenger injured in traffic accident
0.003 0.996 0.000
V15.4 Driver injured in traffic accident
0.003 0.996 0.000
V15.3 Person injured while boarding or alighting
0.003 0.996 0.000
V15.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.996 0.000
V15.1 Passenger injured in nontraffic accident
0.003 0.996 0.000
V15.0 Driver injured in nontraffic accident
0.003 0.996 0.000
V16.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.996 0.000
V16.5 Passenger injured in traffic accident
0.003 0.996 0.000
V16.4 Driver injured in traffic accident
0.003 0.996 0.000
V16.3 Person injured while boarding or alighting
0.003 0.996 0.000
V16.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.996 0.000
V16.1 Passenger injured in nontraffic accident
0.003 0.996 0.000
V16.0 Driver injured in nontraffic accident
0.003 0.996 0.000
V19.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.003 0.996 0.000
I65.1 Occlusion and stenosis of basilar artery
0.003 0.996 0.000
V11.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.996 0.000
V11.5 Passenger injured in traffic accident
0.003 0.996 0.000
V11.3 Person injured while boarding or alighting
0.003 0.996 0.000
V11.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.996 0.000
V11.1 Passenger injured in nontraffic accident
0.003 0.996 0.000
V11.0 Driver injured in nontraffic accident
0.003 0.996 0.000
V19.8 Pedal cyclist [any] injured in other specified transport accidents
0.003 0.997 0.000
V11.4 Driver injured in traffic accident
0.003 0.997 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.000 0.997 0.003
V14.5 Passenger injured in traffic accident
0.003 0.997 0.000
V14.3 Person injured while boarding or alighting
0.003 0.997 0.000
V14.2 Unspecified pedal cyclist injured in nontraffic accident
0.003 0.997 0.000
V14.1 Passenger injured in nontraffic accident
0.003 0.997 0.000
V14.0 Driver injured in nontraffic accident
0.003 0.997 0.000
V14.9 Unspecified pedal cyclist injured in traffic accident
0.003 0.997 0.000
M06.4 Inflammatory polyarthropathy
0.003 0.997 0.000
V13.28 Pedal cyclist injured in collision with car, pick-up truck or van; unspecified pedal cyclist injured in nontraffic accident; while engaged in other specified activities
0.003 0.997 0.000
V13.49 Pedal cyclist injured in collision with car, pick-up truck or van; driver injured in traffic accident ; during unspecified activity
0.003 0.997 0.000
V13.99 Pedal cyclist injured in collision with car, pick-up truck or van; unspecified pedal cyclist injured in traffic accident; during unspecified activity
0.003 0.997 0.000
V14.4 Driver injured in traffic accident
0.003 0.997 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.997 0.003
I47.1 Supraventricular tachycardia
0.003 0.997 0.000
M06.46 Inflammatory polyarthropathy (Lower leg)
0.003 0.997 0.000
M70.75 Other bursitis of hip-Pelvic/Thigh
0.003 0.997 0.000
M70.6 Trochanteric bursitis
0.003 0.997 0.000
V19.29 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in nontraffic accident; During unspecified activity
0.003 0.997 0.000
V19.69 Unspecified pedal cyclist injured in collision with other and unspecified motor vehicles in traffic accident: Unspecified place
0.003 0.997 0.000
V19.99 Pedal cyclist [any] injured in unspecified traffic accident; during unspecified activity
0.003 0.997 0.000
R63.8 Other symptoms and signs concerning food and fluid intake
0.000 0.997 0.003
V12.48 Pedal cyclist injured in collision with two- or three-wheeled motor vehicle; driver injured in traffic accident ; while engaged in other specified activities
0.003 0.997 0.000
N32.3 Diverticulum of bladder
0.000 0.997 0.003
I08 Multiple valve diseases
0.003 0.997 0.000
M06.3 Rheumatoid nodule
0.003 0.997 0.000
I05-I09 Chronic rheumatic heart diseases
0.003 0.997 0.000
S80.7 Multiple superficial injuries of lower leg
0.003 0.997 0.000
Z84 Family history of other conditions
0.003 0.997 0.000
M06.32 Rheumatoid nodule (Upper arm)
0.003 0.997 0.000
H02.1 Ectropion of eyelid
0.000 0.997 0.003
M06.36 Rheumatoid nodule (Lower leg)
0.003 0.997 0.000
C24.8 Overlapping lesion of biliary tract
0.000 0.997 0.003
S32 Fracture of lumbar spine and pelvis
0.003 0.997 0.000
M06.49 Inflammatory polyarthropathy (Site unspecified)
0.003 0.997 0.000
I42.2 Other hypertrophic cardiomyopathy
0.000 0.997 0.003
S40.9 Superficial injury of shoulder and upper arm, unspecified
0.000 0.997 0.003
M06.34 Rheumatoid nodule (Hand)
0.003 0.997 0.000
X41.9 Unspecified place
0.000 0.997 0.003
M06.48 Inflammatory polyarthropathy (Other)
0.002 0.997 0.000
M06.47 Inflammatory polyarthropathy (Ankle and foot)
0.002 0.997 0.000
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)
0.002 0.997 0.000
M06.44 Inflammatory polyarthropathy (Hand)
0.002 0.997 0.000
M06.43 Inflammatory polyarthropathy (Forearm)
0.002 0.997 0.000
M06.42 Inflammatory polyarthropathy (Upper arm)
0.002 0.997 0.000
M06.41 Inflammatory polyarthropathy (Shoulder region)
0.002 0.997 0.000
S32.1 Fracture of sacrum
0.002 0.997 0.000
M06.37 Rheumatoid nodule (Ankle and foot)
0.002 0.997 0.000
S06.30 Focal brain injury (without open intracranial wound)
0.003 0.997 0.000
S32.10 Fracture of sacrum (closed)
0.002 0.997 0.000
I08.9 Multiple valve disease, unspecified
0.002 0.997 0.000
I09 Other rheumatic heart diseases
0.002 0.998 0.000
C24.1 Ampulla of Vater
0.000 0.998 0.002
J32.8 Other chronic sinusitis
0.000 0.998 0.002
T84.8 Other complications of internal orthopaedic prosthetic devices, implants and grafts
0.002 0.998 0.000
M70.7 Other bursitis of hip
0.002 0.998 0.000
S01.1 Open wound of eyelid and periocular area
0.000 0.998 0.002
D46.2 Refractory anaemia with excess of blasts
0.002 0.998 0.000
M70.68 Trochanteric bursitis-Other
0.002 0.998 0.000
M70.67 Trochanteric bursitis-Ankle/Foot
0.002 0.998 0.000
M70.66 Trochanteric bursitis-Lower Leg
0.002 0.998 0.000
M70.64 Trochanteric bursitis-Hand
0.002 0.998 0.000
M70.63 Trochanteric bursitis-Forearm
0.002 0.998 0.000
M70.62 Trochanteric bursitis-Upper arm
0.002 0.998 0.000
M70.61 Trochanteric bursitis-Shldr region
0.002 0.998 0.000
M70.60 Trochanteric bursitis-Mult sites
0.002 0.998 0.000
L40.9 Psoriasis, unspecified
0.002 0.998 0.000
T51 Toxic effect of alcohol
0.000 0.998 0.002
Z84.2 Family history of other diseases of the genito-urinary system
0.002 0.998 0.000
X62 Intentional self-poisoning by and exposure to narcotics and psychodysleptics [hallucinogens], not elsewhere classified
0.000 0.998 0.002
I06 Rheumatic aortic valve diseases
0.002 0.998 0.000
M06.39 Rheumatoid nodule (Site unspecified)
0.002 0.998 0.000
M06.38 Rheumatoid nodule (Other)
0.002 0.998 0.000
M06.35 Rheumatoid nodule (Pelvic region and thigh)
0.002 0.998 0.000
M06.31 Rheumatoid nodule (Shoulder region)
0.002 0.998 0.000
Z84.0 Family history of diseases of the skin and subcutaneous tissue
0.002 0.998 0.000
M70.69 Trochanteric bursitis-Site unspec
0.002 0.998 0.000
S91.0 Open wound of ankle
0.002 0.998 0.000
D35.2 Pituitary gland
0.000 0.998 0.002
R94.3 Abnormal results of cardiovascular function studies
0.000 0.998 0.002
S83.2 Tear of meniscus, current
0.002 0.998 0.000
M06.30 Rheumatoid nodule (Multiple sites)
0.002 0.998 0.000
M06.33 Rheumatoid nodule (Forearm)
0.002 0.998 0.000
L40.8 Other psoriasis
0.002 0.998 0.000
Z84.3 Family history of consanguinity
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.